x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Neurology Today in 5

Neurology Today

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

science & medicine medicine

All Episodes

04:51

Food deserts and stroke risk, physical activity in...

Neurology Today in 5 ·

2025/09/18

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, “food deserts,” and stroke risk; why staying active may reduce cognitive decline in patients with Parkinson's disease; and how initiating rimegepant for migraine could help reduce opioid and butalbital use.

en

04:27

Parkinson’s and dementia with Lewy bodies blood test,...

Neurology Today in 5 ·

2025/09/04

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson’s disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epilepsy.

en

03:52

Small fiber neuropathy, Dr. Merit Cudkowicz,...

Neurology Today in 5 ·

2025/08/21

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Merit Cudkowicz, MD, MSc, FAAN, recipient of this year’s AAN Lifetime Achievement Award for Clinically Relevant Research; and how neurologist couples pursue work-life balance.

en

04:10

Divisive treatment for cluster headache, head...

Neurology Today in 5 ·

2025/08/07

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how positioning the head flat before a thrombectomy benefited patients with large vessel occlusion stroke; and what rural neurology looks like in 2025, the first story in our new series, Neurology in America.

en

04:34

New treatment for giant-cell arteritis, links between...

Neurology Today in 5 ·

2025/07/17

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.

en

04:51

Telomere length and and risk for neurologic...

Neurology Today in 5 ·

2025/07/03

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles on the association of shortened telomeres on risk for stroke, late-life depression and dementia; affect of research funding cuts on tenure/promotion opportunities; and herpes zoster vaccine and reduced dementia risk.

en

04:14

Post-TIA fatigue, neurologic complications of...

Neurology Today in 5 ·

2025/06/19

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.

en

04:27

Post-TIA fatigue, neurologic complications of...

Neurology Today in 5 ·

2025/06/05

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.

en

04:14

Advances in cell therapies for Parkinson’s, GLP-1...

Neurology Today in 5 ·

2025/05/15

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson’s, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny.

en

04:16

Microplastics in brain, salary gap in neurology, the...

Neurology Today in 5 ·

2025/05/01

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles finding microplastics in the brain postmortem linked to dementia, the salary gap between men and women neurologies, and neurologists studying the impact of microgravity on the brain.

en

04:41

Impact of high-dose Vitamin D on MS relapse, the role...

Neurology Today in 5 ·

2025/04/17

In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell repair that preceded the appearance of MS lesions; and a discussion of the challenges and opportunities of using AI in neurology education.

en

04:35

New approved drug for neurofibromatosis 1 with...

Neurology Today in 5 ·

2025/04/03

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.

en

05:06

Impact of NIH cuts on neurology research, response to...

Neurology Today in 5 ·

2025/03/20

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting.

en

04:44

Lifetime burden of dementia, hidden features on EEGs...

Neurology Today in 5 ·

2025/03/06

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled program that detects hidden features in EEGs for epilepsy detection, and neurology-trained pharmacists who are working with neurology departments.

en

05:25

IVF and MS relapse, community-based neurologists...

Neurology Today in 5 ·

2025/02/20

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associated with loneliness, social isolation and brain function, and the role of community-based neurologists in drug development.

en

04:49

Remote neurology education, tirzepatide for...

Neurology Today in 5 ·

2025/02/06

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.

en

04:24

Middle meningeal artery embolization and subdural...

Neurology Today in 5 ·

2025/01/16

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors’ picks for the best advances of 2024.

en

04:59

Magnesium sulfate for cerebral palsy, novel gene...

Neurology Today in 5 ·

2025/01/02

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.

en

05:20

Revised criteria for diagnosing MS, AI for...

Neurology Today in 5 ·

2024/12/19

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.

en

05:02

3-year outcomes for anti-NMDAR encephalitis, skin...

Neurology Today in 5 ·

2024/12/05

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.

en

138 results

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe